Journal of Nanobiotechnology | Targeting microglial circMBNL1 opens up a new nanomedicine treatment strategy for major depression
QQ Academic Group: 1092348845
Detailed
This work expands the nucleic acid targets for depression from neurons to microglia and uses peptide-guided nanoparticles for intranasal brain delivery, bypassing the blood-brain barrier. In the futur
- Previous: Chemical Engineering J
- Next: Bioactive Materials |

mxene academic